Published online May 27, 2024. doi: 10.4240/wjgs.v16.i5.1271
Revised: February 5, 2024
Accepted: April 8, 2024
Published online: May 27, 2024
Processing time: 204 Days and 20.3 Hours
Da Vinci Robotics-assisted total mesorectal excision (TME) surgery for rectal cancer is becoming more widely used. There is no strong evidence that robotic-assisted surgery and laparoscopic surgery have similar outcomes in elderly pa
To determine the improved oncological outcomes and short-term efficacy of ro
A retrospective study of the clinical pathology and follow-up of elderly patients who underwent TME surgery at the Department of Gastrointestinal Oncology at the Affiliated Hospital of Nanjing University of Chinese Medicine was conducted from March 2020 through September 2023. The patients were divided into a robot-assisted group (the R-TME group) and a laparoscopic group (the L-TME group), and the short-term efficacy of the two groups was compared.
There were 45 elderly patients (≥ 60 years) in the R-TME group and 50 elderly patients (≥ 60 years) in the L-TME group. There were no differences in demo
The curative effect and short-term efficacy of robot-assisted TME surgery for elderly patients with rectal cancer are similar to those of laparoscopic TME surgery; however, robotic-assisted surgery has better short-term outcomes for individuals with risk factors such as obesity and pelvic stenosis. Optimizing the learning curve can shorten the operation time, reduce the recovery time of gastrointestinal function, and improve the prognosis.
Core Tip: Previous studies have shown that laparoscopic total mesorectal excision (TME) surgery for rectal cancer has been widely used worldwide. Robotic-assisted systems are capable of achieving finer anatomical manipulation and better surgical outcomes with high-definition cameras, but TME surgery has not been widely promoted in elderly rectal cancer patients. In this retrospective study, we enrich the evidence that robotic-assisted systems deserve to be widely used over laparoscopy.
